Keywords: Alzheimer's Disease, Gray Matter1H-MRSI can examine spatiotemporal characteristics of metabolic dysfunction in multiple brain regions in early Alzheimer’s disease (AD) pathology. Since both cortical and subcortical gray matter structures have shown vulnerability to AD neurodegeneration, we tested whether regional gray matter metabolic abnormalities were associated with (i) APOE4 genotype, a risk factor for amyloid burden, (ii) CSF p-tau181, an indicator of tau burden, and (iii) morphometry metrics (volume, cortical thickness) indicative of neurodegeneration, in cognitively unimpaired elderly. We found lower caudate Cho and lower posterior cingulate Glx in APOE4 carriers compared to non-carriers. There were no metabolite relationships with CSF p-tau181 or morphometry.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords